Dennis I. Goldberg
Amministratore Delegato presso Nexus Therapeutics, Inc.
Profilo
Dennis I.
Goldberg was the founder of Transport Pharmaceuticals, Inc. (founded in 1999) where he held the title of President & Chief Executive Officer.
Dr. Goldberg was also the founder of Transcend Therapeutics, Inc., Talaria Therapeutics, Inc...
Dr. Goldberg's current job(s) included being the Chief Executive Officer & Director at Senex Biotechnology, Inc., the President & Chief Executive Officer at Nexus Therapeutics, Inc., the President & Director at LipimetiX Development LLC, and the President at Benu BioPharma, Inc.Dr. Goldberg's former job(s) included being the President, Chief Executive Officer & Director at BZL Biologics, Inc., the Director, VP-Development & Regulatory Affairs at eXIthera Pharmaceuticals, Inc., and the VP-Product Development & Regulatory Affairs at GelTex Pharmaceuticals, Inc.Dr. Goldberg's education history included obtaining a doctorate degree from Temple University (Pennsylvania).
Posizioni attive di Dennis I. Goldberg
| Società | Posizione | Inizio |
|---|---|---|
Nexus Therapeutics, Inc.
 Nexus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of NB Therapeutics, Nexus Therapeutics, Inc. is a company that provides biopharmaceutical management services. The company is based in Framingham, MA. The CEO of the company is Dennis I. Goldberg. Nexus Therapeutics was acquired by Transport Pharmaceuticals, Inc. on August 14, 2006. | Amministratore Delegato | - |
Benu BioPharma, Inc.
 Benu BioPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Benu BioPharma, Inc. operates a biopharmaceutical development management and consulting company. Its services include development, consulting, product specific services and portfolio triage. The company is headquartered in Natick, MA. | Presidente | - |
LipimetiX Development LLC
 LipimetiX Development LLC Pharmaceuticals: MajorHealth Technology LipimetiX Development LLC operates as a biopharmaceutical company. It develops drugs for the treatment of refractory hypercholesterolemia and hypertriglyceridemia, acute pancreatitis, coronary artery, and peripheral artery diseases by decreasing arterial cholesterol content and inflammation. The company is headquartered in Natick, MA. | Presidente | - |
Senex Biotechnology, Inc.
 Senex Biotechnology, Inc. BiotechnologyHealth Technology Senex Biotechnology, Inc. is a drug discovery and development company focused on oncology therapeutics. The company was founded by Igor B. Roninson and is headquartered in Columbia, SC. | Amministratore Delegato | - |
Precedenti posizioni note di Dennis I. Goldberg
| Società | Posizione | Fine |
|---|---|---|
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Direttore/Membro del Consiglio | - |
Talaria Therapeutics, Inc.
 Talaria Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Esperion Therapeutics, Inc., Talaria Therapeutics, Inc. researches and develops technology for treating cardiovascular disease. The company is based in West Conshohocken, PA. Talaria Therapeutics was acquired by Esperion Therapeutics, Inc. on September 30, 2000 for $20.32 million. The company was founded by Dennis I. Goldberg, Chuck G. Hadley. | Amministratore Delegato | - |
| BZL Biologics, Inc. | Amministratore Delegato | - |
Transcend Therapeutics, Inc.
 Transcend Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transcend Therapeutics, Inc. develops and markets pharmaceutical products. It offers its products for oxidative stress, cytokine dysfunction, and multiple organ dysfunctions. The company was founded by Dennis I. Goldberg and Gary W. Pace in 1992 and is headquartered in Cambridge, MA. | Fondatore | - |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Consigliere Generale | - |
Formazione di Dennis I. Goldberg
| Temple University (Pennsylvania) | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Health Technology |
Transcend Therapeutics, Inc.
Transcend Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transcend Therapeutics, Inc. develops and markets pharmaceutical products. It offers its products for oxidative stress, cytokine dysfunction, and multiple organ dysfunctions. The company was founded by Dennis I. Goldberg and Gary W. Pace in 1992 and is headquartered in Cambridge, MA. | Health Technology |
Transport Pharmaceuticals, Inc.
 Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA. | Health Technology |
Senex Biotechnology, Inc.
Senex Biotechnology, Inc. BiotechnologyHealth Technology Senex Biotechnology, Inc. is a drug discovery and development company focused on oncology therapeutics. The company was founded by Igor B. Roninson and is headquartered in Columbia, SC. | Health Technology |
eXIthera Pharmaceuticals, Inc.
eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Health Technology |
Talaria Therapeutics, Inc.
Talaria Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Esperion Therapeutics, Inc., Talaria Therapeutics, Inc. researches and develops technology for treating cardiovascular disease. The company is based in West Conshohocken, PA. Talaria Therapeutics was acquired by Esperion Therapeutics, Inc. on September 30, 2000 for $20.32 million. The company was founded by Dennis I. Goldberg, Chuck G. Hadley. | Commercial Services |
Nexus Therapeutics, Inc.
Nexus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of NB Therapeutics, Nexus Therapeutics, Inc. is a company that provides biopharmaceutical management services. The company is based in Framingham, MA. The CEO of the company is Dennis I. Goldberg. Nexus Therapeutics was acquired by Transport Pharmaceuticals, Inc. on August 14, 2006. | Commercial Services |
| BZL Biologics, Inc. | |
Benu BioPharma, Inc.
Benu BioPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Benu BioPharma, Inc. operates a biopharmaceutical development management and consulting company. Its services include development, consulting, product specific services and portfolio triage. The company is headquartered in Natick, MA. | Commercial Services |
LipimetiX Development LLC
LipimetiX Development LLC Pharmaceuticals: MajorHealth Technology LipimetiX Development LLC operates as a biopharmaceutical company. It develops drugs for the treatment of refractory hypercholesterolemia and hypertriglyceridemia, acute pancreatitis, coronary artery, and peripheral artery diseases by decreasing arterial cholesterol content and inflammation. The company is headquartered in Natick, MA. | Health Technology |
- Borsa valori
- Insiders
- Dennis I. Goldberg
